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m1078105 Non-Black Minoritiaa and Outcoma in thaNational Ragiatry of Myocardial Infarction 2
(NRMI 2)
J.G. Canto,H.A. Taylor,Jr., B. Sandereon, W.J. Rogers for the NRMI 2
Investigators. University of A/abama Medical CerrteriBirmingham, AL, USA
Few reports have examined treatment patterns and outcomes among His-
panics, Asians and Native Americans with acute myocerdial infarction. Data
from the NRMI 2, which has enrolled 275,046 patients from June 1994 to
April 1998, was analyzed to better understand the presenting characteristics,
treatment patterns, and mortality among non-Black minorities compared to
Whites.
Whites Hispanics Asians N Amer
N 236,166 6,696 2,725 S13
Meanage, years 67” 63* 65* 61t
Male, % 63 65* 66” 67t
Diabetee mellitus,% 24 38* 32* 38*
Hypertension,% 48 51* 53* 49
Sx onset to arrival, min 122 135* 128 144*
Acute repetiusion,% 38 36 36 39
Coronary angiogrem,‘A 39 43* 39 41
PTCA or CABG, ‘A 23 24* 23 21
Unadjustedmortality,‘A 10,3 8.5$ 10.2 10,6
lps 0.001; tps 0.01; *ps 0.05 compared to Whites
After adjusting for relevant factors, no significant differences in overall
mortality were present between White and non-Black minorities.
Conclusions: Among patient8 hospitalized with acute myooardial infarc-
tion, non-Black minorities compared to Whites are frequently younger, male,
have a higher prevalence of diabetes and hypertension, and preeent much
Iatertothe hospital after the onset of symptoms. However,once in the hoepi-
tai, non-Black minorities areas likely ae Whites to receive acute reperfusion
therapy, undergo coronary angiography and subsequent revaecularization.
There are minimal differences in hospital mortality among the groups.
m1078106 Mortality, Morbidity, Raaouraa uaa and Quality of
Life Following Q- va Non-Q-Wave Infarction and
Thrombolytlc Tharapy: A GUSTO-1Subatudy
A. Barbagelata, R.M. Califf, E.B. Sgarboesa, S. Goodman, D. Knight,
D.B. Mark, C.B. Granger, M.D. Benezzi, A. Calve, K. Gates, D.A. Agranatti,
S. Starr, Q. Song, B. Mautner, G.S. Wagner. Fundacion Favaloro, Buenos
Aires, Argentina, Duke Clinical Research Inst., Durham, NC, USA
Non-Q-wave Ml post-thrombolysis may carry lower mortality than Q-wave
Ml but alao more angina and resource use and poorer quality of life. We
etudied this hypothesis for non-Q- (n = 555) vs Q-wave (n = 1275) first Ml in
the GUSTO-1Economica/Quality of Life substudy. Baseline factors in Q and
non-Q wave pts. included age 59 (both); malee 74%, 66?.; Killip 188%,90Yo;
anterior Ml 84%, ss~o.
30days 1yaar
Q non-tl P Q nOn-Q P
Mortality,% 4.5 1.6 0.01 6.6 4.7 0.04
Cheet pain,% 31 29 0.38 23 22 0.70
Dyepnea, “A 30 29 0.84 31 33 0.52
Angiogrephy,‘A 5.2 6.9 0.15 19 21 0.56
PTCA, % 2.4 4.3 0.02 11 12 0.90
CABG, % 1.3 1.6 0.53 6.2 5.4 0.59
Rehospitalized,% 10 13 0.09 37 40 0.53
Well-being,median 32 32 0.22 34 33 0.05
DASI, median 19 19 0.42 37 33 0.31
Conclusion: Ptswith non-Q wave Ml poet-thrombolysiehave lower 30day
and l-year mortality, but no increase in angina or interventions and similar
quality of life when compared to pts with Q wave Ml.
I 1078-107] laThereaRalatiOnahiP BetweentheUtili~tion
of Cardiac Procedural for Acuta Myocardial
Infarction and the On-Site Availability of Thoaa
Servicaa?
J.G. Canto, W.J. Rogers, W.J. French, J.M. Gore, NC. Chandra, R. Perdok
for the NRMI 2 Investigators. University of A/abama Medical CenteL
Birmingham, AL, USA
In-hoepitel availability of services may be a very important determinant of
their use. Data from 275,046 patients enrolled in the National Regietryof My-
ocardial Infarction 2 were analyzed to determine the correlation (r) between
theavailabilityof cardiac procedures and the proportion who underwent euch
s.ewiceaby each payer woup among the 9 US Census regions. Only those
regions with at least 7 participating hospitele were included in thie analyeie.
Payer % USCensus RegionsCATH PTCA CABG
r pvalue r pvalue r pvalue
All 0.925 <0.001 0.971 <0.001 0.827 <0.001
Medicare 56 0.960 <0.001 0.927 <0.001 0.842 <0.001
Private 26 0,676 0.004 0.952 <0,001 0.830 <0.001
HMO 8 0.721 0.11 0.636 0.04 0.960 <0.001
SeK-pay 6 0.730 0.16 0.616 0.09 0.866 0.06
Medicaid 3 0,844 0.16 0.790 0.21 0.811 0.09
%Arr “o1>60 r = 0.925p <0.0014020
50 70 90
%Aveilebiliry
% Angiogrsphyvs “AAvailabilityfor all patientsby the 8 US Cenaus regions
Conclusion: For the overall population, there is a strong correlation ba-
tween the on-site hospital availability and utilization of coronary angiography,
angioplasty or bypase surgery among the US Census ragions. This relation-
ship, which aiao appears throughout each payer group, is atrongest amongat
the three largest payers (madicare, private, and HMO) with the others show-
ing important trends towards this association.
-f impOtt8nCeOfpOateri0rChaatf-aadain
Suapactad Acute Myocardial Infarction with
Non-diagnostic Routine ECG
J. Agarwal, K. Khaw, F.Aurignac, A. LoCurto. UMDNJ-Roberl Wood
Johnson Medical School, New Brunswick, NJ, USA
Thrombolylic therapy has become a standard treatment for acute myooar-
dial infarction (Ml). However, many patients do not receive thrombolytic
therapy either because of contraindications or absence of ST elevation in
routine ECG. Circumflex coronary arfety (Cx) occlusions frequently affect the
posterior part of the heart. Hence posterior leads (VT-poeterior-axillary Hne,
Ve-inferiorangleof s=pula, Vdeff pare-ve~ebrel area) were recorded in 33
patiente suspected of acute Ml with non-diagnostic 12-lead ECG. Of these,
12 patients (6 male, 4 female, mean age 59 years) showed only posterior
injury patfern. Of the remaining 21 patients, 10 had non-Q Ml, and 11 ruled
out for Ml. Of the 12 patients with posterior Ml, the ECG patterns were the
followings: 8 patiente showed more than 1 mm ST elevation and 4 showed
significant Q-waves in 2 or 3 poeterior Ieade, 4 had signifioent R wavee in
V1-V2,and 6 had ST depression in anterior leads. CPK’S with positive CPK-
MB were notad in 10 of 12 patients, vatying from 723 to 7562. One patient
died before CPKSwere available.
CoronaryAngiogremof 12 PosteriorMl CulpritVeeeel
No SignificantIeaions”(n= 1) None
Oneveesal diseeee (n = 5) Cx in 5
Multiveeeeldiseaae (n = 4) Cx in 4
CABG (n = 2) Native Cx in 1 & OM CABG in 1
*Thie patienthad no CPK apillage.
Of the 33 patients screened, two patients had received thrombdytic treat-
ments, because of ST elevations in wsterior leads.
Conclusion: 1) pcsterior leads are helpful in suspected acute Ml with non-
diagnostic routine ECG. 2) Isolated posterior lead ST elevation is usually
acoompaniad by Cx occlusion.
m1078109 Aaaociation of Dapraaaad 24-Hour Heart RateVariability with Mortality in the EMIAT Trial
M. Malik, A.J. Carom, D.G. Julian, G. Frangin, M.J. Janse, P.J. Schwartz,
P.Simon for the EMIAT investigatora. St. George’s l-fospita/Medica/ School,
London, England, Sanofi Recheroha, Montpelliec France
The EMIAT trial investigated the effects of Amiodarone vs Placebo in post
infarction patients with left ventricular ejection fraction (LVEF) s 40% and
age s 75 years. This etudy investigated the association of reduction of
baeeline 24-hour heart rate variability (HRV) with cardiac arrhyfhmic and
cardiac non-arrhythmiadeath in pts of the EMIAT trial. Baeeline 24-hour HRV
data were available in 11S1 pta (592 in Placebo group) in whom 67 (Plac8bo
40) cardiac arrhythmia and 59 (Placebo 25) cardiac non-arrhythmia deaths
were recorded during a follow-up of up to 2 years. By varying the dichotomy
limits of HRVtriangular index in a systematic fashion, a statistical association
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of cardiacmortality with reduction of 24-hour HRV was examined in both
Amiodarone and Placebo groups.
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The results (Figures: full line = arrhyfhmic mortality, dashed line = non-
arrhythmic mortality) show that while inPlacebo group, reduced HRV was
strongly associated with arrhythmicbut not non-arrhythmia mortality, the op-
posite wee true in the Amiodarone treatad group. Thus the study confirms
that also in patients with reduced LVEF,HRV is a strong predietor of arrhyth-
mia mortality. The study further suggests that some patients who would die
an arrttythmic death auffer a non-arrhythmia death when on Amiodarone.
m1078122 Identification and Management of High-RiskPatiente With Acute Mvocerdial Infarction: The
National Regiatry of M~ocardial Infarction
M. Burns, R.C. Becker, J.M. Gore, C. Lambrew, W. French, W. Rogers for
the National Registry of Myocardial Infarction (NRMI-2) Investigators.
Unive~ifyof Massachusetts Medical Schrwl, Worceste6 MA, USA
High stendarda of cost-effective medical care require practical methods for
riakstratifieation and timely appropriation of available treatmenta. The NRMl-
2 Riak Aeseesmant was validated using a database including over 200,0fYJ
patients with myoeardial infarction (Ml). Independent predictors of an adverse
in-hospital outcome were: Killip IV (OR 4.46), systolic BP <100, pulse >100
(OR 2.0) Killip Ill (OR 1.59), age=- 70 yeare (OR 1.42), Killip II (OR 1.41),
STelevation on initial ECG (OR 1.32), anterior site of Ml (OR 1.23) and prior
Ml. (OR,1.10) (all p <0.001 except age p -= 0.01). Thrombolytice (47.5 vs
18.6Y0;p = 0.0001) and either IQ PTCA or emergent CABG (9.3 vs 5.IYo;
p = 0.0001) were utilized more often in the eaffy management of high than
low-risk patients. Door-to-drug (91 versus 62 minutes; p = 0.0001), door-
to-balloon (247 versus 161 minutes; p = 0.0001) and door to bypaas (439
veraus 300 minutes; p = O.OQOI)times were all lower in high-risk patients.
Mortality among high-riak patients receiving thrombolytic tx (n = 26,367) IQ
PTCA/CABG (n = 5,1S1) and thoae without repetiusion (n = 23,973) was
6.1%, 10.3%, and 21.4%, respectively (p = 0.0001). Risk stratifieetlon is
possible using readily available demographic, ECG and clinical information.
The NRMI-2 Risk Assessment Assignment provides insight into health care
trends in the U.S.
H1078123 Vagal Reflexes and Left Ventricular Function inPeat-Mvocardial Infarction Patients: Results
from th~ ATRAMI Study
M.T. La Revere, A. Mottara, S.H. Hohnloaer, J.T. Bigger, Jr., F.1.Marcus,
R. Nohara, P.J.Schwartz for the ATRAMI Investigators. “S. Maugeri”
Foundation, /RCCS, Montesceno Pavia, Italy Universifyof Pavia, Italy
Unequivocal data have shown that Baroreflex Sensitivity (BRS) is depressad
in post myoeardial infarction patienta but whenever is logical to assume
that the larger the infarct size the lower the baroreceptore’ response, the
relationship between the autonomic derangement and ventricular function
has not been fully elucidated. in the ATRAMI (Autonomic Toneand Reflexes
After Myocardial Infarction) study 1176 out of 1264 patienta had both BRS
(phenylephtfne method) and LVEF (Echo, Angio or MUGA) (mean BRS 7.2
+4.9 mdmmHg, LVEF49 *2%) measured within one week. The correlation
between BRS and LVEF,as well as between BRS and CPK Ievela(n = 1026)
was weak (respactivaly, r = 0.17 and r = 0.06). However, when LVEF was
categorizedin 3 groups (S 35, 3e-50, > 50%), a more depressed BRS was
detected in the lowest LVEF group (4.9+ 3.8 vs 7.4 + 4.6 and vs 7.7 +5,
both p -=0.001) and the number of patients with a markedly depressed BRS
(<3 ma/mmHg) was significantly highar among patients with reduced LVEF
as compared to patients with LVEF 36-50% and > 50% (34% vs 14% and
11% ~5@ively, p < o.01). In the ATRAMI study survival analysis showed
the depraeead BRS (-=3 me/mmHg) and reduced LVEF (S 35%) were both
independent predictors d survival (Muitivariate RR 2.8 (95Y0Cl 1.2-6.1) for
BRS and RR 4.7 (95% Cl 2.0-10.8) for LVEF). Moreover the presence of
both depressed LVEF and BRS significantly increaaad the RR to 13.4 (95%
Cl 6.6-27.4).
Conclusion: In poet-Ml patients baroreflex activity is weakly related to
the extent of ventricular damage as measured by LVEF. Both indexes of
ventricular and autonomic dyafunetion are independently associated with a
poor prognosis and the combination of BRS and LVEF is of meaningful value
in the identification of patients at increased risk for cardiac mortality.
I1078-124I kI-ho5PitalAdverse Cardiac Eventa Following
First Myocardial Infarction Ara Similar Among
African-Americans and Caucasian
F. Khaja, H.N. Sebbah, M. Alam, G. Divine, S. Borzak, S. Smith,
K.G. Richer-Cornish, S. Goldstein. Henry Ford lfeartand Vaacu/ar/rrstitute,
Detroit, Ml, USA
Itiegenerally believed that African-Americans (AA) experience greater ad-
verse cardiacevents following an acute myocardial infarction (AMI) compared
to Caucasians (C). In the present study, we prospeefively examined the in-
hospital adverse cardiac events in a cohort of 392 consecutive patients (125
AA and 267 C) with a firet AMI admitted to the cardiac intensive care unit
during a period of 4 yeare. A patient was considered to have had an advarae
cardiac event if one of the following occurred during the index hospitalization:
death, ventricular fibrillation (VF) or ventricular tachycardia (VT), pulmonary
congestion (PC) orcardiogenic shock (CS), reinfaretion (Rl) or post-infarction
angina (PIA).
AA c Relative Risk and P-value
(%) (%) 950/.Confldsncs Intervsl
Death 6 3 1.42 (0.52, 3.91) 0.49
VF or VT s 10 0.79 (0.40, 1.5s) 0.51
PC or SC 21 20 1,03 (0,6S, 1,56) 0.90
RI or PIA 22 20 1,13 (0.75, 1.69) 0.56
Any Event 37 42 0.s7 (0.66, 1.14) 0.30
The data indicate that, following first AMI, in-hospital adverae events are
not statistically different between AA and C. This lack of difference between
races is maintained even after adjusting forage and gender (Cox regression).
We conclude that AA experience similar rates of in-hospital adverse cardiac
events after a first AMI as C.
1078-125 Chlamidia Pneumonia Infection and
Atherosclerotic Coronary Disease
M. Pence, R. Sessa, M. Di Pietro, A. Vatveri, G. Aurigemma, F. Fadele,
M. Del Piano, A. Dagianti. Department of Cardiovaecu/ar and Ffespiratory
Sciences and Department of Microbiology, La Sapienza fJniverai& Rome,
Italy
Objectives: The aim of this study was to asaess the incidence of Chlamidia
pneumonia antibodies in patients with angiographically verified atheroscle-
rotic coronaryartery disease (CAD). Methods: 114consecutive patients were
investigated between April 1994 and June 1995. Patients ware divided into
two groups: one of 72 patients with acute myocardial infarction (AMI) (53
men, 19 women, mean age 62.57 + 10.12), the other of 42 patients with
chronic ischemic heart disease (37 men, 5 women, mean age 62.75+ 9.26).
Identification of Chlamidia pneumonia was cerriad out with the micro im-
munofluorescence method (Alifax), on serum samples taken from patients
on the day after admission to the hospital. The lgG and lgA anti-Chlamidia
pneumonia titre was assessed, values> 1.32 and> 1:8 being respectively
considered significant. Resu/ts.’outof72 patients with AMI, 67.9% and 37.7%
of the 53 men had a significantly high lgG and lgAtitre respectively; out of 19
women 31% and 15.8%had a significantly high lgG and lgAtitre respectively.
Out of 42 patients with chronic ischemic haarl disease, 45.9Y0and 35% of
the 37 men had a significantly high lgG and lgA titre respectively; only one
woman out of 5 had a high lgG and lgA titre. Conclusion: These date show
that after AMI, in a high percentage of patients there is an abnormally high
antibody lgG and lgA titre, the former being more significant. A high antibody
titre in a smaller percentage of patients in the group with chronic ischemic
heart disease suggests that there may be an exacerbation of Chlamidia
pneumonia infection during AMI, but these data do not provide evidence of
a direct linkand aclear relationship between Chlamidia pneumonia infeetion
and clinical symptoms of atherosclerotic coronary disease.
~ DeterminantsofLongTerm Cardiovascular Drug
Uae After Myocardial Infarction: Does Country
Make a Difference?
A.M. Ross, J.S. Reiner, K.S. Coyne, Y.C. Draoui, C.F. Lundergan. The
Gaorge Washington University Washington, DC, USA
International clinical trials have uncovered substantial differences in adjunc-
tive treatments post myoeardial infarction (Ml) between countries despite
rapid information axchange between continents. We examined 2 year follow-
up data from 1S46 patients in the GUSTO-1 angiographic study to identify
